Business Wire
11 Jun 2026, 20:39 UTC · 15w ago
Verdict
Headline takes no side. We score XERS +0.80 across one claim — strongly bullish.
+0.80strongly bullish
More positive than 88% of ticker scores this week
What the story claims
1 claim · scored −1 bearish … +1 bullish
The USPTO has issued a Notice of Allowance for Xeris Pharmaceuticals' U.S. Patent Application No. 17/151,405 regarding compositions and methods of use.
So whatPatent allowances protect intellectual property and extend market exclusivity, which typically increases the valuation of biopharmaceutical companies.
More positive than 93% of claims this week
Which stocks this story touches
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 88% of ticker scores this week
The company received a Notice of Allowance from the USPTO for a patent application, strengthening its intellectual property portfolio.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
1h ago
+41.0%
Price agrees with the score
$9.77 vs $6.93 close before publication (Jun 11) · not market-adjusted
XERS chart →
